Podcast Episodes
Back to SearchIDO Target Perseverence With IO Biotech's Mai-Britt Zocca, Ph.D.
We love to hear from our listeners. Send us a message.
Under the leadership of Mai-Britt Zocca, Ph.D., IO Biotech is advancing novel, immune-modulati…
3 years, 7 months ago
Pursuit Of A Universal Flu Vaccine With Longhorn Vaccines & Diagnostics' Jeff Fischer
We love to hear from our listeners. Send us a message.
With a unique multi-target approach, what it considers the world's best adjuvant, and a host o…
3 years, 7 months ago
Genetic Testing & Neurodegenerative Disorders With AviadoBio's Lisa Deschamps
We love to hear from our listeners. Send us a message.
Lisa Deschamps' story is one of determination and fortitude. She got her start in the life sci…
3 years, 7 months ago
Biotech M&A Anomalies With Allan Shaw
We love to hear from our listeners. Send us a message.
While many clinical-stage biopharmas are contracting or holding the line through the current m…
3 years, 7 months ago
Observations On Outsourcing With Molecule to Market's Raman Sehgal
We love to hear from our listeners. Send us a message.
Raman Sehgal has made a career out of putting his energy— and he's got a lot of it— into build…
3 years, 8 months ago
What's A Biologic Revolution? With Vaxxinity's Mei Mei Hu, J.D.
We love to hear from our listeners. Send us a message.
Vaxxinity CEO Mei Mei Hu, J.D. leads a company with some lofty ambitions. The democratization …
3 years, 8 months ago
Creative Capital Generation With James Thomas Coates, Ph.D.
We love to hear from our listeners. Send us a message.
As biotech capital markets continue to restrict access to funding for emerging biopharmas, you…
3 years, 8 months ago
Oligonucleotide Opportunities in DMD with PepGen's James McArthur, Ph.D.
We love to hear from our listeners. Send us a message.
Among the more prevalent genetic conditions, Duchenne muscular dystrophy affects an estimated…
3 years, 8 months ago
Changing The Diabetes Care Paradigm With Arecor's Dr. Sarah Howell
We love to hear from our listeners. Send us a message.
While renal disease treatment technologies have seen moderate incremental improvements, there …
3 years, 9 months ago
Innate Immunity & Mouse Models With LIfT Biosciences' Alex Blyth
We love to hear from our listeners. Send us a message.
Serial inventor and entrepreneur Alex Blyth had long held interests in health and science, but…
3 years, 9 months ago